2.3912

1.58% -0.0388

Black Diamond Therapeutics Inc (BDTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.43

Offen:

$2.44

24-Stunden-Volumen:

448.85K

Relative Volume:

0.38

Marktkapitalisierung:

$133.54M

Einnahmen:

Nettoeinkommen (Verlust:

$-82.44M

KGV:

-1.0488

EPS:

-2.28

Netto-Cashflow:

$-66.75M

1W Leistung:

-16.08%

1M Leistung:

-25.50%

6M Leistung:

-51.88%

1J Leistung:

+7.25%

1-Tages-Spanne:

$2.31

$2.47

1-Wochen-Bereich:

$2.31

$2.86

52-Wochen-Spanne:

$2.155

$7.66

Black Diamond Therapeutics Inc Stock (BDTX) Company Profile

Firmenname

Black Diamond Therapeutics Inc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

617-417-5868

Adresse

ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

BDTX's Discussions on Twitter

Vergleichen Sie BDTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BDTX	2.39	133.54M	0	-82.44M	-66.75M	-2.28
VRTX	449.69	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	748.75	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	588.46	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.89	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.52	24.89B	3.30B	-501.07M	1.03B	11.54

Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-07-31	Eingeleitet	Raymond James	Outperform
2023-07-14	Eingeleitet	Piper Sandler	Overweight
2023-06-30	Hochstufung	Stifel	Hold → Buy
2023-06-28	Hochstufung	H.C. Wainwright	Neutral → Buy
2023-06-27	Hochstufung	Wedbush	Neutral → Outperform
2022-03-29	Herabstufung	Wedbush	Outperform → Neutral
2022-03-22	Herabstufung	H.C. Wainwright	Buy → Neutral
2021-09-30	Eingeleitet	Stifel	Hold
2021-01-07	Eingeleitet	Wedbush	Outperform
2020-11-24	Eingeleitet	Berenberg	Buy
2020-05-04	Eingeleitet	H.C. Wainwright	Buy
2020-02-24	Eingeleitet	Canaccord Genuity	Buy
2020-02-24	Eingeleitet	Cowen	Outperform
2020-02-24	Eingeleitet	JP Morgan	Overweight
2020-02-24	Eingeleitet	Jefferies	Buy

Alle ansehen

Black Diamond Therapeutics Inc Aktie (BDTX) Neueste Nachrichten

Nov 16, 2024

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Decrease in Short Interest - MarketBeat

Nov 16, 2024

Nov 14, 2024

T. Rowe Price Investment Management, Inc. Expands Stake in Black Diamond Therapeutics Inc - GuruFocus.com

Nov 14, 2024

Vestal Point Capital, LP Increases Stake in Black Diamond Therap - GuruFocus.com

Nov 14, 2024

Nov 08, 2024

What is HC Wainwright's Estimate for BDTX FY2024 Earnings? - MarketBeat

Nov 08, 2024

Wedbush Has Optimistic View of BDTX FY2024 Earnings - MarketBeat

Nov 08, 2024

Nov 06, 2024

Black Diamond Therapeutics (NASDAQ:BDTX) Receives "Buy" Rating from HC Wainwright - MarketBeat

Nov 06, 2024

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 06, 2024

Nov 05, 2024

Black Diamond Therapeutics Reports Promising Q3 2024 Results - TipRanks

Nov 05, 2024

Black Diamond: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 05, 2024

BDTXBlack Diamond Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024

Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks - Simply Wall St

Nov 05, 2024

Black Diamond's BDTX-1535 Shows 42% Response Rate in Lung Cancer Trial, Reports Q3 Results | BDTX Stock News - StockTitan

Nov 05, 2024

Nov 01, 2024

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 01, 2024

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Growth in Short Interest - Defense World

Nov 01, 2024

Oct 31, 2024

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 5.9% in October - MarketBeat

Oct 31, 2024

Oct 26, 2024

Foundations Investment Advisors LLC Has $445,000 Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World

Oct 26, 2024

Oct 16, 2024